Showing results (921-930 of 4,380) with videos related to
Sort By:
Pageof 438
ACS Medicinal Chemistry Letters|May 14, 2025
Novel Bicyclic DGK Inhibitors for Treating Metastatic MelanomaRam W SabnisACS Medicinal Chemistry Letters|May 14, 2025
Targeted Degradation of BCL6 Using Novel Bifunctional Degraders: A New Therapeutic Strategy for BCL6-Positive CancersRobert B KargboACS Medicinal Chemistry Letters|May 14, 2025
Novel Azaindole Compounds as Phosphodiesterase 4B Inhibitors for Treating Immune-Inflammatory Diseases or DisordersZhendong Song, Steven H LiangACS Medicinal Chemistry Letters|May 14, 2025
Novel Bicyclic Heterocycles as MRGPRX2 Antagonists for Treating Inflammatory DiseasesRam W SabnisACS Medicinal Chemistry Letters|May 14, 2025
Novel Piperidinylpyridinylcarbonitrile Derivatives as QPCT and QPCTL Inhibitors for Treating CancerRam W SabnisACS Medicinal Chemistry Letters|May 14, 2025
Novel Tricyclic Compounds as GSK3 InhibitorsYinlong Li, Steven H LiangACS Medicinal Chemistry Letters|May 14, 2025
Targeting Phantom Pain with Psilocybin: Toward Integration with Adaptive Sensory TechnologiesRobert B KargboACS Medicinal Chemistry Letters|May 14, 2025
Synthesis, Radiosynthesis, in Vitro and in Vivo Evaluation of the GABAA-Benzodiazepine Receptor Agonist [11C]RO6899880Faustine d'Orchymont, Junchao Tong, Neil VasdevACS Medicinal Chemistry Letters|May 14, 2025
Development of Novel Gastrin-Releasing Peptide Receptor-Targeted Radioligand with Albumin Binder to Improve Accumulation in TumorShohei Tsuchihashi, Kazuma Nakashima, Hiroyuki Watanabe, et al.ACS Medicinal Chemistry Letters|May 14, 2025
Discovery of a Novel [6-6-5-5-6] Pentacyclic Tetrahydrocyclopentaphthalazinone as a Promising PARP Inhibitor ScaffoldYagmur U Doruk, Morgan E Diolaiti, Alan Ashworth, et al.Pageof 438